News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Konstantinov Konstantin
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/22/2023 |
4
| Konstantinov Konstantin (Director) has filed a Form 4 on REPLIGEN CORP|
Txns:
| Granted 686 shares
@ $0
Granted 1,487 options to buy
@ $156.63, valued at
$232.9k
|
|
| 01/26/2023 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 145,000 options to buy
@ $0.74, valued at
$107.3k
|
|
| 01/23/2023 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Sold 1,069 shares
@ $0.5752, valued at
$614.9
Exercised 2,800 restricted stock units
@ $0 |
|
| 09/20/2022 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 80,000 restricted stock units
@ $0 |
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 11,200 options to buy
@ $5.21, valued at
$58.4k
Granted 16,800 restricted stock units
@ $0 |
|
| 01/21/2022 |
4
| Konstantinov Konstantin (Chief Technology Officer) has filed a Form 4 on Codiak BioSciences, Inc.|
Txns:
| Granted 42,000 options to buy
@ $7.21, valued at
$302.8k
Granted 8,400 restricted stock units
@ $0 |
|
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|